To assess the role of SRC in PGE2 induced EGFR nuclear translocation and its relation with EGFR activation, NSCLC cells were treated with PGE2 in the presence of pharmacological inhibitors of SRC and EGFR. This evidence concerns the gene EGFR and non-small cell lung carcinoma.